tiprankstipranks
Trending News
More News >
Foghorn Therapeutics (FHTX)
NASDAQ:FHTX
US Market
Advertisement

Foghorn Therapeutics (FHTX) Revenue

Compare
414 Followers

Foghorn Therapeutics Revenue

Foghorn Therapeutics had a revenue of 8.15M in the quarter ending Sep 30, 2025, with 7.89%. This bring the company's revenue in the last twelve months to 24.52M, Decreased 1.43%. In the fiscal year ending Dec 31, 2024, Foghorn Therapeutics had annual revenue of 22.60M with -33.83% growth.
Revenue (ttm)
24.52M
Revenue Growth
-3.91%
P/S Ratio
8.83
Revenue/Employee
$201,804
Employees
112
Market Cap
$199.55M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
22.60M-11.55M+66.17%
Dec 31, 2023
34.16M14.93M+177.63%
Dec 31, 2022
19.23M17.91M+1,457.77%
Dec 31, 2021
1.32M889.00K+306.74%
Dec 31, 2020
430.00K-43,000,000.00%
Dec 31, 2019
Dec 31, 2018
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis